Welcome to PsychU!

In a 2013 study focused on antidepressant treatment for MDD, ~42% of variation in medication response was related to genetic variants. This indicates that pharmacogenetic research findings could help practitioners better understand who is at risk for nonresponse.

You must be logged-in to view this content.